Prescription-strength medicine used in hospitals recalled for carcinogen’s presence
Hospitals that use prescription-strength ranitidine (brand name: Zantac) from American Health Packaging need to check their blister packs to see if they’re included in Thursday’s recall.
American Health repackaged Amneal Pharmaceuticals-made ranitidine, which was recalled in November for having more carcinogen NDMA (N-Nitrosodimethylamine) than the FDA allows.
The recall covers 100-count Unit Dose Blister Packs of 150mg ranitidine tablets, lot Nos. 179516 and 179745, expiration 12/31/2019; 180712, expiration 2/29/2020; 180819, expiration 4/30/2020; 181403; 182544, 183155 and 183236, expiration 5/31/2020; 185739; 186600; and 186702, expiration 12/31/2020.
Tablets from the recalled lots should be quarantined from other tablets. Pharmacies that have a recalled lot should call 877-475-5864 for a return packet, Monday through Friday, 9 a.m. to 5 p.m., Eastern time.
Consumers with recalled tablets should stop using them. If you have questions about the recall, call Inmar Pharmaceuticals at 800-967-5952 (option 1), Monday through Friday, 9 a.m. to 5 p.m., Eastern time.
This story was originally published February 27, 2020 at 8:35 PM with the headline "Prescription-strength medicine used in hospitals recalled for carcinogen’s presence."
